google-plus2 facebook < /path> twitter blogger tumblr2 reddit linkedin delicious stumbleupon mail

These step-by-step instructions guide you through the abstract submission process.

Please review the Call for Abstracts, Deadlines, & Fees for general information.

Abstract Title and Submission Type:

Title: 

  • Must be in all capital letters (ALL CAPS)
  • No more than 175 characters (including spaces)
  • If a tissue type is in the title, it should include the species used (e.g. MOUSE RETINA, HUMAN MUSCLE)

Submission Type: Before 12 February, 2018, choose Oral or Poster submission. After 12 February, 2018, only Late-Breaking Submissions will be accepted.

  • Oral
    • To be considered for a twelve (12) minute presentation during a concurrent session
    • If the abstract is not selected for an Oral Presentation, the accepted abstract is automatically considered for a Poster Presentation
    • A number of Oral Abstracts will be selected to present a Poster Teaser during a Plenary Session. Selected individual may speak for up to one (1) minute to introduce the work on the poster; no application necessary
  • Poster
    • To be considered for presentation of a poster for one hour during one of the meeting’s poster sessions
    • The poster should display text and illustrative material (e.g. photos, tables, charts, etc.)
  • Late-Breaking
    • Only Poster Presentations accepted

Presenter Trainee Status:

For each abstract, the submitter must indicate if the presenting author is a trainee (post-doctoral fellow or currently enrolled in an undergraduate, graduate or medical degree program).

Task List for Each Submission:

Abstract Submission Agreement

Presenting Author: 

  • Each abstract must identify one presenting author who will register and attend the meeting using first name, last name, city, state, country, email, gender, institution/company, and career status (select one option below):
    • Trainee: post-doctoral fellow, graduate, undergraduate, or medical student
    • Early career investigator: independent group leader for seven (7) years or less
    • Senior investigator: independent group leader for more than eight (8) years
  • A presenting author may present a maximum of three (3) poster presentations and one (1) oral presentation during the meeting

Co-Author(s):

Each abstract may have a maximum of 24 co-authors, and must list for each individual: first name, last name, city, state, country, email, and institution/company.

Abstract Details:

Submission Topic: Abstracts will be reviewed within the topics below. Select one:

  • Adipose and Connective Tissue
  • Cancers
  • Cardiac Tissue and Disease
  • Chromatin and Epigenetics
  • Clinical Trials and Regenerative Medicine Interventions
  • Endothelial Cells and Hemangioblasts
  • Epithelial Tissues 
  • Ethical, Legal, and Social Issues; Education and Outreach
  • Eye and Retina
  • Germline, Early Embryo, and Totipotency
  • Hematopoiesis and Immunology
  • Musculoskeletal Tissue
  • Neural Development and Regeneration
  • Neural Disease and Degeneration
  • Organoids
  • Pancreas, Liver, Kidney
  • Placenta and Umbilical Cord Derived Cells
  • Pluripotency
  • Pluripotent Stem Cell Differentiation
  • Pluripotent Stem Cell: Disease Modeling
  • Reprogramming
  • Stem Cell Niches   
  • Technologies for Stem Cell Research
  • Tissue Engineering

Additional Abstract Questions:

  1. Does the research described include a clinical trial or other experimental treatment?
  2. Is the research described in this abstract part of an academic-industry partnership or collaboration?

Awards for Travel, Merit, & Posters:

Only trainee submitters (post-doctoral fellow, graduate, undergraduate, or medical students) who submit abstracts during the regular abstract submission timeline and are ISSCR trainee members are eligible. 

To apply, select your interest for the appropriate award(s) during the online abstract submission process:

  • ISSCR 2018 Travel Awards 
  • ISSCR 2018 Outstanding Poster Presentation Awards 

Abstract Text: 

Abstracts must be no more than 2,000 characters, not including spaces and written as one condensed paragraph.

Abstract text should not include section titles (e.g., methods, results, etc.), tables, graphs, charts, diagrams, authors, references, or acknowledge funding sources.

Funding Source:

Limited to 200 characters with spaces, submitters may include funding source information that will appear in the print and electronic abstract publication.

Concurrent Session Topics (Oral Submissions Only):

Choose up to two (2) Concurrent Session topics that best fit your abstract’s research to be considered by the Program Committee: 

  • Cardiac Development and Disease
  • Disease Modeling
  • Epigenetics and Genetic Regulatory Networks
  • Epithelial Stem Cells
  • Ethics
  • Gene Editing
  • Hematopoiesis
  • Homeostasis, Metabolism and Aging 
  • Mechanisms of Reprogramming I: to pluripotency
  • Mechanisms of Reprogramming II: transdifferentiation between lineages

  • Muscle Stem Cells
  • Nervous System Disease 
  • Neural Development
  • Organoids in Modeling Disease and Development
  • Stem Cell Niches
  • Road to the Clinic
  • Stem Cells and Cancer
  • Stem Cells in Organ Development and Maintenance
  • Technology Frontiers
  • Tissue Engineering

Payment:

All prices in USD. Non-refundable. 

  • Payment must be made via credit card
    • Each regular abstract submission is $60
    • Late-Breaking Abstract submission fee is $90